|
Single metal and metal oxide nanoparticles
|
| TiO2 (un-/doped) |
PRESAGE phantom |
kV Photons |
• X-ray energy differential therapeutic effects observed in PRESAGE |
94 and 182–184
|
|
In vitro
|
MV photons |
• NP radioenhancement effect during MV X-ray irradiation explained by increased ROS generation |
|
In vivo
|
|
• Rare earth dopants (e.g. Sm, Gd, Nd, Eu, Er, Tb) increased X-ray induced ROS, and apoptosis markers |
|
| (PAA-) TiO2/H2O2
|
In vitro
|
kV Photons |
• NPs increased intracellular H2O2 concentrations by gradual release thereof leading to increased radiotherapy efficiency |
163, 185 and 186
|
|
In vivo
|
|
• Increased ˙OH radical and H2O2 concentration, DNA damage and apoptosis during X-ray irradiation |
|
| MnFe2O4
|
In vitro
|
kV Photons |
• Oxygen delivery via catalytic H2O2 decomposition |
144 and 187
|
|
In vivo (normoxia and hypoxia) |
MV photons |
• Hypoxic conditions were alleviated in vitro and in vivo
|
|
|
• Decreased HIF-1a levels, and increased apoptosis and DNA damage under irradiation during hypoxic conditions |
|
|
• Immune-modulating effect: suppression of PD-L1 expression and increased infiltration of T cells even after irradiation |
|
|
• PEGylated NPs showed good cytocompatibility, passive tumor accumulation, O2 generation via H2O2 decomposition, GSH consumption via glutathione-peroxidase-like activity, enhanced ROS and double-strand break levels in hypoxic conditions, and hypoxia attenuation and good radioenhancement efficiency in vivo. |
|
| SPIONS (γFe2O3, Fe3O4) |
In vitro
|
kV Photons |
• Excellent biocompatibility |
81
|
|
|
• Increased ROS production via Fenton and Haber–Weiss reactions from released iron ions and catalytically active nanoparticle surface |
|
|
• X-ray irradiation led to additional oxidative stress from increased catalytically active nanoparticle surfaces |
|
| CuO |
In vitro
|
MV photons |
• Increased ROS levels with X-ray treatment and CuO NPs |
83
|
|
In vivo
|
|
• Increased radiosensitivity by the NP-induced modulation of the cell cycle distribution towards increased G2/M phase |
|
|
• Increased level of self-destructive autophagy observed with the combination of CuO NPs and X-rays |
|
| ZnO |
In vitro
|
kV Photons |
• Radioenhancing effects explained by increased apoptosis and DNA damage; oxidative stress as possible driver identified |
188–191
|
|
In vivo
|
MV photons |
• Discussed cytotoxic effects of ZnO: dissolution of Zn++ in acidic conditions; e−h+ pair production even in the dark leading to surface ROS production |
|
|
• Discussed genotoxic effects of ZnO: oxidative stress |
|
|
• Gd-doped ZnO NPs increased cells in G1 phase and decreased DNA repair efficiency |
|
|
• ZnO-CaffeicAcid NPs showed radioenhancement via ROS/oxidative stress generation, DNA damage, DNA repair, and mitochondrial dysfunction, suppression of cell cycle checkpoint machinery and cell death promotion (via apoptosis, necrosis, and disregulations of gene and protein expressions) |
|
| Y2O3
|
In vitro
|
kV Photons |
• Increased ROS and DNA double-strand breaks with NPs alone or in combination with X-rays |
103
|
|
|
• NPs affected irradiation induced DNA damage and repair response |
|
|
• Synergistic effects of NP treatment and irradiation proposed by clonogenic assay |
|
| Ag |
In vitro
|
MV photons |
• Increased apoptosis levels after irradiation with Ag NPs |
192–197
|
|
In vivo
|
|
• Antiproliferative activity in combination with radiotherapy |
|
|
• Decrease of mitochondria membrane potential, promotion of apoptosis and enhanced destructive autophagy under irradiation in hypoxic conditions with Ag NPs |
|
|
• Increased ROS and protective autophagy during irradiation with Ag NPs |
|
|
• Radiosensitization might be Ag+ cation release dependent |
|
| Gd chelate (AGuIX) |
In vitro
|
kV Photons, |
• Good safety profile |
2, 178 and 198–202
|
|
In vivo
|
In human |
• Rapid and safe renal elimination |
|
MV photons |
• Preferential accumulation in tumor due to EPR effect after intravenous injection |
|
MeV hadrons |
• Possible emission of low-energy photoelectrons and Auger electrons leading to higher ROS |
|
|
• Dose enhancement higher for kV than MV photon, and C6+ than He2+ ion irradiation |
|
|
• Photon radiation-induced ROS and DNA double-strand break increase and DNA repair reduction observed |
|
|
• Ion irradiation increased DNA damage mediated by ROS |
|
| Gd2O3
|
In vitro
|
kV Photons |
• Compared to a solution of separate Gd-atom species, Gd2O3 NPs showed higher ROS generation, suggesting a Gd–Gd interatomic de-excitation-driven nanoradiator effect |
203 and 204
|
|
MeV protons |
• Increased hydroxyl radical and ROS production, increased DNA double-strand breaks and cell cycle arrest at G2/M phase |
|
C6+ ions |
• Increased apoptosis and cytostatic autophagy identified as radiosensitization mechanism |
|
| HfO2 (NBTXR3) |
In vitro
|
kV Photons |
• NBTXR3 has a good safety profile and improves radiotherapy efficiency via physical mechanisms |
4, 24, 156–159 and 205–208
|
|
In vivo
|
In human |
• Increased necrosis, DNA double-strand breaks, micronuclei formation and an activation of the cGAS-STING pathway detected after irradiation |
|
MV photons |
• In combination with radiotherapy: enhancement of early apoptosis, early necrosis and late apoptosis/necrosis; abscopal effects driven by an increased CD8+ cell infiltration |
|
|
• Modulation of the immunopeptidome observed in vivo leading to an anti-tumor immune response |
|
| WO3−x
|
In vitro
|
kV Photons |
• Increased DNA double-strand breaks and apoptosis after irradiation with NPs |
209 and 210
|
|
In vivo
|
|
• Remarkable synergistic effect of radiotherapy and phototherapy (PTT/PDT) |
|
| Pt |
In vitro
|
kV Photons |
• ROS scavenging capabilities of Pt NPs during irradiation detected, which might counteract nanoparticle radioenhancement |
70 and 211–213
|
|
MV photons |
• Pt NPs amplified radiation therapy by confined production of ROS in nano-volumes around nanoparticles |
|
C6+ ions |
• Amplified DNA damage detected during hadron therapy |
|
| Au |
In vitro
|
kV Photons, |
• Physical, chemical and biological mechanisms described |
1, 45, 104, 109, 121, 124, 176 and 214–220
|
|
In vivo
|
MV photons, |
• Less radioenhancement observed at MV compared to kV irradiations |
|
Protons |
• Observed enhancement effects at MV energies cannot be explained by physical effects |
|
|
• Enhancement effects are cell-line specific |
|
|
• Cell cycle arrest in G2/M phase has been observed for some cell lines |
|
|
• Cytoplasmic damage can drive DNA damage; mitochondrial function identified as possible driver |
|
|
• Increased DNA dmage and/or mitochondrial and/or ER stress with and/or without irradiation lead to increased apoptosis and/or necrosis |
|
|
• Au NPs have radiosensitization effect via various biological mechanisms, such as weakening the detoxification system |
|
| Bi2O3
|
In vitro
|
kV Photons |
• In vitro enhancement ratio for kV irradiation higher compared to MV irradiation |
62, 66 and 221
|
|
MV photons |
• Monte Carlo studies predicted dose enhancement for kV irradiation but not for MV irradiation |
|
|
• Radiocatalytic surface of NPs hypothesized to lead to water splitting |
|
| BiFeO3
|
Gel dosimetry |
kV Photons |
• Promising results in radiotherapy amplification, magnetic hyperthermia and imaging |
222
|
|
In vitro
|
|
|
|
| BiGdO3
|
MAGIC gel dosimeter |
kV Photons |
• Multifunctional pegylated nanoparticles showed radiation enhancement in gel dosimetry, in vitro and in vivo. |
223
|
|
In vitro
|
|
|
|
In vivo
|
|
|
|
| Bi2WO6
|
In vitro
|
kV Photons |
• Bi2WO6 generated radiocatalytic ROS in an acellular system, with ˙OH as main oxidative species identified |
224
|
|
In vivo
|
MV photons |
• Radiosensitization in vitro was found in a clonogenic assay together with increased ROS and DNA double strand break levels |
|
|
• Efficient radiotherapy enhancement shown in vivo without toxicity effects in the time span of 30 days. |
|
|
Hybrid nanoparticle systems
|
| Au–TiO2 hybrid |
In vitro
|
kV Photons |
• Production of large amount of ROS during irradiation |
225
|
|
In vivo
|
|
• Synergistic X-ray therapeutic effect of Au and TiO2 due to their interfacial contact |
|
| Au@MnO2-PEG |
In vitro
|
kV Photons |
• O2 generation from H2O2 decomposition via MnO2 shell and relieve of cellular hypoxia |
226
|
|
In vivo
|
|
• H2O2 decomposition led to Mn2+ release and enhanced T1-weighted MR imaging |
|
|
• Compared to the individual components, Au@MnO2 core@shell hybrid NPs led to synergistic radioenhancement effects in vitro and in vivo and to more increased double-strand breaks and apoptosis levels |
|
| Au@Pt nano-dendrites |
In vitro
|
Photons (energy N/A) |
• Integration of CT imaging, PTT & RT with synergistic therapeutic effects |
227
|
|
| Au:Pt-PEG |
Plasmid DNA
|
kV Photons |
• NPs enhanced the MV X-ray induced double-strand breaks in plasmid DNA mainly by influencing the chemical stage that takes place after the physical interaction |
228 and 229
|
|
In vitro
|
MV photons |
• NP radioenhancing effect with kV X-rays observed in vitro and in vivo by enhancing double-strand breaks, apoptosis and relieving of hypoxia via H2O2 decomposition |
|
In vivo
|
|
|
|
| WS2:Gd3+-PEG 2D-nanoflakes |
In vitro
|
Photons (energy N/A) |
• Triple-modal imaging: CT/MR/photo acoustic |
230
|
|
In vivo
|
|
• Synergistic PTT/RT therapeutic effects observed |
|
|
• X-ray enhanced DNA double-strand breaks observed |
|
| Gd2(WO4)3:10%Tb@PEG/MC540 |
In vitro
|
kV Photons |
• X-ray induced generation of 1O2 observed from photo excitation of surface coupled merocyanine (MC) 540 |
231
|
|
In vivo
|
|
• Synergistic radioenhancement and PDT effects observed in vitro and in vivo
|
|
|
• Dual-modal imaging properties (CT/MR) |
|
| Fe3O4@Ag |
In vitro
|
MV photons |
• Synergistic radioenhancement effects of the Fe3O4 core and Ag shell as compared to the individual components alone |
232
|
|
|
• Radiosensitivity enhancement through decrease of the cytoprotective autophagy at an early stage, followed by an increase of calcium-dependent apoptosis at a later stage |
|
| Gd2O3/BSA@MoS2-HA |
In vitro
|
kV Photons |
• Enhanced DNA double-strand breaks in combination with X-rays in vitro
|
233
|
|
In vivo
|
|
• In vivo tumor growth inhibition in combination with X-rays |
|
|
• Best therapeutic effects in combination with X-ray and PTT treatments |
|
|
• In vivo multimodal imaging properties (MSOT/CT/MR) |
|
| BiNPs@SiO2@BamCS/PCM |
In vitro
|
kV Photons |
• Acellular detection of elevated ROS (˙OH, 1O2 and ˙O2−) under X-ray irradiation |
234
|
|
In vivo
|
|
• Elevated cell death, ROS and DNA double-strand breaks detected in combination with X-rays in vitro
|
|
|
• Depleted GSH levels due to hyperthermia-released and H2O2-activated proalkylation agent BamCS |
|
|
• Excessive ROS and irreversible depletion of endocellular GSH led to cell death via mitochondria-mediated apoptosis pathway |
|
|
• Tumor growth inhibition in combination with X-rays |
|
|
• Synergistic PTT/RT effects observed |
|
|
Nanoscale metal–organic frameworks (nMOFs)
|
| MnTCPP–Hf–FA |
In vitro
|
kV Photons |
• O2 generation via catalytic H2O2 decomposition |
235
|
|
In vivo
|
|
• Decreased HIF-1a expression suggested hypoxia alleviation due to intracellular H2O2 decomposition and O2 generation |
|
|
• Increased ROS levels and DNA double-strand breaks after irradiation even in hypoxic conditions |
|
| UiO-66-NH2(Hf) |
In vitro
|
Photons (energy N/A) |
• Radioenhancement due to increased ROS levels, DNA double-strand breaks and cell apoptosis |
236
|
|
In vivo
|
|
|
|
| Hf6-DBB-Ru |
In vitro
|
kV Photons |
• MOFs accumulated in mitochondria through cationic nature of Ru-based photosensitizer |
237
|
|
In vivo
|
|
• Irradiation induced ˙OH radical generation from Hf6 units and 1O2 generation from the DBB-Ru photosensitizer |
|
|
• Clonogenic radioenhancement effects observed, along with increased double-strand break, 1O2, lipid peroxidation (COX-2 upregulation) and apoptosis/necrosis levels after irradiation |
|
|
• Irradiation induced depolarization of the mitochondrial membrane leading to cytochrome c release and caspase-3 activation (apoptosis pathway) |
|
|
• Effective in vivo tumor regression after intratumoral or intravenous nMOF administration and low dose (6 or 8 Gy) X-ray therapy, with increased levels of necrosis and apoptosis. |
|
| W18@Hf12-DBB-Ir |
In vitro
|
kV Photons |
• Hierarchical assembly of Hf12, DBB-Ir, and W18 generated 3 distinct ROSs: ˙OH, 1O2 and ˙O2−, respectively |
238
|
|
In vivo
|
|
• Irradiation in vitro lead to enhanced ROS, DNA double-strand breaks and apoptosis/necrosis |
|
|
• Superb anticancer efficacy (>99% tumor growth inhibition) on two in vivo tumor models with irradiation |